American Century Companies’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $89.2M | Buy |
1,616,008
+384,300
| +31% | +$20.8M | 0.05% | 483 |
|
|
2025
Q4 | $60.4M | Buy |
1,231,708
+147,119
| +14% | +$6.86M | 0.03% | 642 |
|
|
2025
Q3 | $46.8M | Buy |
1,084,589
+162,861
| +18% | +$6.36M | 0.02% | 737 |
|
|
2025
Q2 | $35.4M | Buy |
921,728
+216,892
| +31% | +$8.29M | 0.02% | 817 |
|
|
2025
Q1 | $27.3M | Buy |
704,836
+51,971
| +8% | +$1.9M | 0.02% | 881 |
|
|
2024
Q4 | $22.1M | Buy |
652,865
+58,056
| +10% | +$2.09M | 0.01% | 994 |
|
|
2024
Q3 | $24.3M | Buy |
594,809
+50,730
| +9% | +$2.08M | 0.01% | 938 |
|
|
2024
Q2 | $20.9M | Buy |
544,079
+161,448
| +42% | +$6.79M | 0.01% | 940 |
|
|
2024
Q1 | $16.4M | Buy |
382,631
+45,561
| +14% | +$1.88M | 0.01% | 1004 |
|
|
2023
Q4 | $12.5M | Buy |
337,070
+79,907
| +31% | +$2.87M | 0.01% | 1058 |
|
|
2023
Q3 | $9.32M | Sell |
257,163
-154,791
| -38% | -$5.49M | 0.01% | 1087 |
|
|
2023
Q2 | $14.7M | Buy |
411,954
+50,123
| +14% | +$1.8M | 0.01% | 894 |
|
|
2023
Q1 | $12.9M | Buy |
361,831
+46,144
| +15% | +$1.61M | 0.01% | 919 |
|
|
2022
Q4 | $11.1M | Buy |
315,687
+76,139
| +32% | +$2.54M | 0.01% | 936 |
|
|
2022
Q3 | $7.05M | Buy |
239,548
+96,556
| +68% | +$3.66M | 0.01% | 1004 |
|
|
2022
Q2 | $7.78M | Buy |
142,992
+8,621
| +6% | +$476K | 0.01% | 989 |
|
|
2022
Q1 | $7.32M | Buy |
134,371
+49,628
| +59% | +$2.7M | 0.01% | 1002 |
|
|
2021
Q4 | $4.67M | Buy |
84,743
+4,648
| +6% | +$242K | ﹤0.01% | 1080 |
|
|
2021
Q3 | $3.83M | Buy |
80,095
+17,226
| +27% | +$865K | ﹤0.01% | 1098 |
|
|
2021
Q2 | $3.13M | Buy |
62,869
+26,055
| +71% | +$1.25M | ﹤0.01% | 1097 |
|
|
2021
Q1 | $1.64M | Buy |
36,814
+5,023
| +16% | +$228K | ﹤0.01% | 1230 |
|
|
2020
Q4 | $1.46M | Sell |
31,791
-2,243,063
| -99% | -$103M | ﹤0.01% | 1142 |
|
|
2020
Q3 | $107M | Buy |
2,274,854
+558,440
| +33% | +$28M | 0.09% | 241 |
|
|
2020
Q2 | $87.5M | Buy |
1,716,414
+1,658,536
| +2,866% | +$85.1M | 0.08% | 256 |
|
|
2020
Q1 | $2.74M | Buy |
57,878
+46,016
| +388% | +$2.45M | ﹤0.01% | 804 |
|
|
2019
Q4 | $697K | Buy |
+11,862
| New | +$660K | ﹤0.01% | 1133 |
|
Other funds holding GSK
JEST
